Niloofar Farhang

Title: Niloofar Farhang: Innovator in RNA-Guided Therapeutics

Introduction

Niloofar Farhang is a prominent inventor based in Salt Lake City, UT. She has made significant contributions to the field of RNA-guided transcriptional regulation, particularly in the treatment of back pain. With a total of 2 patents, her work is paving the way for innovative therapeutic approaches.

Latest Patents

Niloofar Farhang's latest patents focus on RNA-guided transcriptional regulation and methods for treating back pain. The disclosed compositions include vectors that comprise nucleotide sequences encoding one or more CRISPR-Cas system guide RNAs and an RNA-directed nuclease. The methods involve modulating the expression of genes in a cell using these compositions, introducing a CRISPR-Cas system into a cell, and treating subjects with lower back pain, including cases caused by degenerative disc disease.

Career Highlights

Throughout her career, Niloofar has worked with esteemed institutions such as the University of Utah Research Foundation and Duke University. Her research has significantly advanced the understanding of gene modulation and its applications in pain management.

Collaborations

Niloofar has collaborated with notable colleagues, including Robert Daniel Bowles and Joshua Stover. These partnerships have further enriched her research and innovation efforts.

Conclusion

Niloofar Farhang is a trailblazer in the field of RNA-guided therapeutics, with her innovative patents and collaborations contributing to advancements in pain treatment. Her work exemplifies the potential of genetic engineering in addressing complex medical challenges.